Find the best pharmaceutical companies to work for

Building families and helping people live better lives. • Guidelines: https://t.co/5aDAoDV3H2

Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Ventana manufactures over 250 cancer tests with related instruments in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world.

Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. In the generic pharmaceuticals market, the Company focuses on controlled-release generic versions of brand-name pharmaceuticals, covering a range of therapeutic areas. In the brand-name pharmaceuticals market, the Company is developing products for the treatment of central nervous system (CNS) disorders. The Company's brand-name product portfolio consists of development-stage projects to which the Company applies its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. It operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceuticals Division (Impax Division).

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co.,

8676 Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson.

Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri . The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.

Elanco is a global animal health company that benefits people as well as animals through their vision: food and companionship enriching life.

5764914 Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Otsuka America Pharmaceutical, Inc. researches, develops, manufactures, and markets pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health in North America. The company focuses on a portfolio of products in neuroscience, oncology, cardio-renal, and medical device markets. It offers pharmaceutical products, including tablets and injections or conditioning agents; and medical devices, including urea breathe test devices. The company was founded in 1989 and is based in Rockville, Maryland. Otsuka America Pharmaceutical, Inc. operates as a subsidiary of Otsuka America, Inc.

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

Par Pharmaceutical, Inc. develops, manufactures, and distributes generic drugs in the United States. The company was incorporated in 2003 and is based in Spring Valley, New York. Par Pharmaceutical, Inc. operates as a subsidiary of Endo International plc.

Lundbeck Inc., a pharmaceutical company, is engaged in the research, development, production, marketing, and sale of therapies for neurologic and psychiatric disorders. The company focuses on developing therapies for brain disorders, such as mood disorders, depression and anxiety, psychosis, epilepsy, Alzheimer s disease, and stroke. Its late-stage research pipeline includes therapies/psychiatry products in development for mental health disorders, as well as neurology compounds/products under investigation for Alzheimer s disease and epilepsy. The company markets its products through a specialty sales force in the United States. Lundbeck Inc. was formerly known as OVATION Pharmaceuticals, Inc. and changed its name to Lundbeck Inc. in March 2009. The company was founded in 2000 and is based in Deerfield, Illinois. It has research facility in Paramus, New Jersey. As of March 19, 2009, Lundbeck Inc. operates as a subsidiary of H. Lundbeck A/S.

Shire Pharmaceuticals, Inc. develops, manufactures, markets, and sells pharmaceutical products. It focuses on central nervous system, gastrointestinal, general products, renal diseases, and human genetic therapies. The company offers ADDERALL and ADDERALL XR for attention deficit hyperactivity disorder (ADHD); REMINYL for Alzheimer's; and CARBATROL for epilepsy. It also develops a range of treatments for ADHD to treat children, adolescents, and adults, as well as researches on non-scheduled compounds. The company markets its products to defined customer groups, such as specialist doctors. It has sales and marketing infrastructure with a portfolio of products targeting the United States, Canada, the United Kingdom, France, Germany, Ireland, Italy, and Spain markets. Shire Pharmaceuticals, Inc. has distributors in Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea, and Thailand. The company was incorporated in 2004 and is based in Wayne, Pennsylvania. Shire Pharmaceuticals, Inc. operates as a subsidiary of Shire plc.

SAFC Biosciences, Inc. manufactures specialty chemicals and biologics for life sciences and high technology commercial applications. It offers flavors and fragrances, amidites, buffers, ultra pure organics, media and feeds, disposables, molecular diagnostics, and active pharmaceutical ingredients, as well as provides the quality controls needed to manage material supply chain risk. This innovative company was founded in 1971 and is headquartered in Lenexa, Kansas.

Sunovion Pharmaceuticals Inc. (formerly Sepracor) engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders, and other illnesses. Its products include LUNESTA medicine that helps people sleep better; XOPENEX levalbuterol HCl inhalation solution; and BROVANA aformoterol tartrate inhalation solution. The company's products also comprise OMNARIS ciclesonide nasal spray; ALVESCO ciclesonide HFA inhalation aerosol; and LATUDA, an oral antipsychotic tablet for the treatment of schizophrenia. It offers products for the treatment of depression, epilepsy, neuropathic pain, and insomnia, as well as respiratory conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary diseases.

DPT laboratories is your CDMO partner for experienced drug formulation and analytical development. It is a cGMP pharmaceutical manufacturing company.

Purdue Pharma LP is a privately held pharmaceutical company founded by physicians more than 60 years ago. They are committed to improving patients' lives in meaningful ways by providing effective therapies along with educational tools that support their proper use. Purdue Pharma is an industry leader in pain medication research and abuse-deterrent technology.

AMAG Pharmaceuticals is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The Company manufactures and sells two approved products, Feraheme (ferumoxytol) Injection for intravenous (IV) and GastroMARK. On June 30, 2009, Feraheme was approved for marketing in the United States by the United States Food and Drug Administration (FDA), for use as an IV iron replacement therapy for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).

NOW Foods complies with all relevant laws and regulations. NOW Foods reserves the right to remove third party comments or posts not consistent with all laws and regulations. We may allow posts on our websites or on our social media sites with which we ...

West-Ward Pharmaceutical Corp. develops, manufactures, and distributes generic pharmaceuticals. The company offers a range of generic pharmaceuticals used in various therapeutic areas, such as analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory, and hormonal areas. It offers products in various dosage forms, including capsules, injectables, solutions, and suspensions. The company also provides contract manufacturing services through its facilities in Eatontown, New Jersey; and Portugal. It offers its pharmaceuticals to chain stores, wholesalers, distributors, health systems, and government agencies in the United States. The company was founded in 1946 and is based in Eatontown, New Jersey. West-Ward Pharmaceutical Corp. operates as a subsidiary of Hikma Pharmaceuticals plc.

West delivers innovative solutions to improve the safe delivery of pharmaceutical, health care and personal care products and is the world's premier manufacturer of components and systems for injectable drug delivery. We serve the world's leading pharmaceutical and biopharmaceutical companies.

Wedgewood Pharmacy is a PCAB -accredited compounding pharmacy. As one of the largest compounding pharmacies in America, we have been serving human-health and animal-health prescribers with custom-compounded medicines since 1981. In fact, more than 30,000 prescribers across the nation turn to Wedgewood Pharmacy for quality, value, choice and service that is legendary. That's because We Care The Way You Care .

Ipsen is a French pharmaceutical company headquartered in Paris, France.

Jazz Pharmaceuticals plc is a biopharmaceutical company based in Ireland.

ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include Trastuzumab-DM1, a Phase II clinical trial product for the treatment of metastatic breast cancer; IMGN901, a Phase I clinical trial product to treat hematological malignancies, including multiple myeloma, small-cell lung cancer, Merkel cell carcinoma, and other cancers of neuroendocrine origin; SAR3419, a Phase I clinical trial product for the treatment of B-cell hematological malignancies, including non-Hodgkin's lymphoma; and IMGN388 and BIIB015, which are in Phase I clinical trials for the treatment of solid tumors. The company's products also comprise BT-062, a Phase I clinical trial product targeting multiple myeloma; SAR566658, a preclinical trail product for the treatment of breast, ovarian, and other solid tumors; SAR650984, a preclinical trail product to treat hematological malignancies; and TAP and other compounds. It has licensing or collaboration agreements with sanofi-aventis; Genentech, Inc.; Biotest AG; Bayer HealthCare AG; Biogen Idec; Amgen, Inc.; Centocor, Inc.; Cytovance Biologics LLC; Laureate Pharma, Inc.; BioInvent International AB; Diosynth RTP, Inc.; and Societa Italiana Corticosteroidi S.r.l. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.

Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It began promoting MERREM I.V. (meropenem for injection) in the U.S. in July 2008. MERREM is an established spectrum antibiotic developed by AstraZeneca. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials; CONSERV-1 and CONSERV-2 for the reduction of blood loss during cardiac surgery; and two Phase 1 programs that address unmet medical needs, one in CDAD (Clostridium difficile-associated diarrhea) and the other in multi-drug resistant (MDR) Gram-negative infections. In addition, the company, in collaboration with Alnylam Pharmaceuticals, Inc., has a pre-IND and a Phase 2 program underway in novel treatments for respiratory syncytial virus infections using Alnylam's RNA-interference technology. Cubist was founded in 1992 and is headquartered in Lexington, Massachusetts.

The world leader in addiction treatment with 20 years of experience and a unique, patient-focused approach. They didn't become the world leader in addiction treatment overnight. Their endeavor started small, with one singular focus - to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They're often unaware of their treatment options, have limited access to treatment, or simply don't seek it out because they're afraid of being stigmatized.

EMD Millipore Corporation provides solutions and services for the research, development, and production of biotechnology and pharmaceutical drug therapies. The company offers analytics and sample preparation products, such as chromolith products, test strips, reference materials, and disinfection controls; biopharmaceutical manufacturing products, such as depth filters, prepacked chromatography columns, resins, and ultrafiltration cassettes; industrial microbiology products that include EZ-products, microbial air monitoring systems, microbial contamination detectors, and granulated media pouches; and IVD/OEM materials and reagents, including bulk and custom antibodies, blood typing monoclonal antibodies, microspheres, and OEM membranes. It also offers life science research products, including antibodies and assays, sterile and non- sterile filtrations, and biomarkers and immunoassays; and reagents, chemicals, and labware products, such as solvents, organic synthesis, and lab cleaning equipment, as well as salts, acids, and caustics. In addition, the company offers small molecule pharmaceuticals products that include silica excipients, polyvinyl alcohols, raw materials, and meglumines; and water purification products, including integral and advantage water purification systems, watercare pacts, and e-solutions. Further, it offers product related services for pharmaceutical research and biotechnology, pharmaceutical, academic, government, clinical, industrial, and research markets worldwide. EMD Millipore Corporation also offers products online. The company was formerly known as Millipore Corporation and changed its name to EMD Millipore Corporation in July 2010. As a result of acquisition of Millipore Corporation by Merck KGaA, its name got changed. The company was founded in 1954 and is based in Billerica, Massachusetts with manufacturing sites and offices worldwide. As of July 15, 2010, EMD Millipore Corporation operates as a subsidiary of Merck KGaA.

Aerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. It focuses on the development of products for the pharmaceutical treatment of glaucoma. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.

Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.

Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people's lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest's current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY.

Merial Limited, an animal healthcare company, engages in the research, development, and production of pharmaceutical products and vaccines for livestock, pets, and wildlife. It offers products in the fields of anaesthetic, antiparasitic, antimicrobial, gastrointestinal, respiratory, and cardiovascular medicines, as well as vaccines to treat diseases, such as Newcastle Disease, Marek's Disease, and Avian Flu in birds. The company's products include IVOMEC for the treatment of parasites in cattle, sheep, and swine; and FRONTLINE for the treatment of dogs and cats. It serves veterinarians, pet owners, farmers, and food animal producers internationally. The company was founded in 1997 through a 50-50 joint venture of the animal health assets of Rhône-Poulenc and Merck & Co , and it is headquartered in Duluth, Georgia. It operates in Argentina, the Netherlands, Australia, New Zealand, Brazil, Philippines, Chile, Russia, China, Singapore, France, Spain, Germany, Taiwan, Italy, Thailand, Japan, the United Kingdom, Korea, the United States, Latinoamerica, Uruguay, Mexico, and internationally. Merial Limited operates as a subsidiary of Sanofi-Aventis, which acquired Rhône-Poulenc and on September 17, 2009 acquired Merck's 50% stake.

Lannett Company, Inc. founded in 1942, develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. Lannett markets its products primarily to drug wholesalers, retail drug chains, distributors, and government agencies. They employ a staff of dedicated people who work together to produce drug products that sick people can afford to buy that will treat their illness, make them well, reduce suffering and improve the quality of their lives.

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. Its therapeutic focus is primarily oncology. Its growing portfolio consists of a diversified selection of clinical candidates both from its own laboratories and from partners. Founded in 2002, Incyte Corporations global headquarters are located in Wilmington, DE, and today, the company employs more than 1,200 people in the US, Europe, and Japan.

Hospira, Inc. is the provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 16,000 employees.

Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.

Allergan, Inc., a subsidiary of Allergan plc., operates as a specialty pharmaceutical company in the United States and internationally. The company offers its products under the Botox and Restasis brands. It markets products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan, Inc. was founded in 1948 and is based in Irvine, California, with operations in approximately 100 countries.

Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada. The company focuses primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the U.S. of products for the treatment of dermatological, aesthetic and podiatric conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions The company offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). The company offers 18 branded products. Its primary brands are PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. The company also sells various other products that it considers less critical to its business. It has various products under development, ranging from new products to existing product line extensions and reformulations of existing products. Products Dermal Restorative Products The company's principal branded dermal restorative products include: RESTYLANE, PERLANE, RESTYLANE FINE LINES and RESTYLANE SUBQ are injectable, transparent, stabilized hyaluronic acid gels, which require no patient sensitivity tests in advance of product administration.

Helping Surgeons Treat Their Patients Better - Arthrex is a global medical device company and leader in new product development and medical education in orthopedics.

Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

Nektar Therapeutics, founded in 1990, is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines. Their drugs are used for the treatments of cancer, auto-immune disease and chronic pain. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. The company employs a team of about 500 dedicated scientists, clinicians and employees that discover medicines for patients with debilitating diseases.

SantenUSA.com - a specialty pharmaceutical offering ophthalmic products & research for retinal disorders, glaucoma, and other eye diseases.

ScriptPro provides pharmacies with powerful robotics, software, and financial tools to grow revenue and leverage automation.

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics' corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.

Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

The United States Pharmacopeia is a pharmacopeia for the United States published annually by the United States Pharmacopeial Convention, a nonprofit organization that owns the trademark and also owns the copyright on the pharmacopeia itself.

Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business. Headquartered in Woodcliff Lake, New Jersey, they are dedicated to a tradition of genuine concern for people and are driven by the desire to help meet the diverse health care needs of patients and their families and caregivers. They are an agile, entrepreneurial organization managed by experienced leadership, backed by the strength, stability and historical successes of Eisai Co., Ltd., which has a strong and lasting commitment to the U.S. market. Their heritage and mission have earned us recognition as an innovative, efficient, solution-oriented pharmaceutical company - a company that effectively works with healthcare professionals, hospitals and managed care organizations to develop and market specialty products that help address unmet needs. Their ability to forge strong alliances gives us a competitive edge. In the United States, their rapid growth and strong performance result from putting patients and their families first when making decisions and from empowering the people who manage their operations. Eisai employees personify their values of integrity, respect, professionalism, quality and teamwork.

ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.

Genoa, a QoL Healthcare Company is the leading pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment community for over 15 years. Our pharmacy and telepsychiatry services impact more than 500,000 individuals annually in 43 states and the District of Columbia. Our network of more than 325 pharmacies fills over 10 million prescriptions annually. Although Genoa specializes in serving individuals with behavioral health and substance use disorders, we are a full-service pharmacy. This means we take care of all the medication needs of our consumers, including prescriptions written by psychiatrists, primary care providers, or other specialty prescribers. Genoa's services are flexible to the many behavioral health, addiction treatment, and primary care delivery models across the country. We have developed services in pharmacy and telepsychiatry to meet the needs of those specific models. None of our service models or pharmacies are the same. We continue to seek opportunities nationwide to help behavioral health and addiction treatment organizations with their pharmacy and telepsychiatry services.

Largest physicians group in WNY with over 500 physicians. One source for the life you live.

Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options. Together with its collaboration partner Astellas Pharma Inc. (Astellas), the Company is developing MDV3100 for multiple stages of advanced prostate cancer. As of December 31, 2011, it completed a Phase III trial in the latest stage. The Company's three subsidiaries include Medivation Prostate Therapeutics, Inc. (MPT), Medivation Neurology, Inc. (MNI) and Medivation Technologies, Inc. (MTI). MPT holds the Company's MDV300 series technology, which is in development for the treatment of advanced prostate cancer, and MTI holds its earlier stage technologies. MNI holds its dimebon technology, which was in development for the treatment of Alzheimer's disease and Huntington disease.

Roche Holdings, Inc., together with its subsidiaries, manufactures and sells pharmaceuticals and diagnostics. Its Pharmaceuticals division provides various prescription pharmaceutical products, such as Rituxan, Avastin, Herceptin, Perjeta, Xolair, Actemra, Lucentis, and Tamiflu. The company s Diagnostics division offers point of care solutions, molecular diagnostics, tissue diagnostics, and immunodiagnostics, as well as diagnostic instruments, reagents, and consumables. It primarily serves the U.S. national wholesale distributors. The company was founded in 1987 and is based in South San Francisco, California. Roche Holdings, Inc. is a subsidiary of Roche Finance Ltd.

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services globally to companies within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IXRS) through to commercial-scale manufacture and companion diagnostic development.Only Almac can combine the expertise, from their specialised teams, to provide you with the right service solutions to help you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation. They are a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo). Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures they are always there to support you across the product development lifecycle.

Purchase influenza vaccines, IVIG, albumin, immune globulin, hyperimmunes, oncology, and coagulation/factor products from a biopharmaceutical supply chain professional

“Albany Molecular Research Inc. provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.”Albany Molecular Research, Inc. (NASDAQ: AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services.

TOLMAR Holdings, Inc. operates as a pharmaceutical company manufacturing generic and in-licensed products. The company was incorporated in 2009 and is based in Fort Collins, Colorado.

Medco Health Solutions of Texas, L.L.C. retails pharmaceuticals through mail orders. The company is based in Irving, Texas. Medco Health Solutions of Texas, L.L.C. is a former subsidiary of Medco Health Solutions, Inc.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company's Endo Pharmaceuticals segment offers branded prescription products,

Astex Pharmaceuticals develops oncology drugs that fights against cancer. It develops a proprietary pipeline of novel anti-cancer therapies and has a number of partnered products being developed under collaborations with pharmaceutical companies. Based in Dublin, California, Astex Pharmaceuticals was founded in 1999.

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.

Upsher-Smith Laboratories, LLC is a trusted US pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. Since 1919, they have formulated and manufactured specialty generics and other products, either independently or with partners, for a wide array of customers, backed by their attentive level of service, their strong industry relationships, and their dedication to uninterrupted supply.

MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards.

The Kelsey-Seybold Clinic is a large multi-specialty clinic system located in Greater Houston with its administrative headquarters in Shadow Creek Ranch, Pearland.

Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.

Serve as a cornerstone in the construction industry while creating value for all stakeholders: customers, employees, suppliers and stockholders.

Quidel was founded in 1979 and eventually launched its first product in 1984. It is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.

Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

Founded in 1954, HD Smith has been focusing on wholesale distribution and specialty solutions. This company provides a complete line of pharmaceutical products as well as business solutions. This company is multi-located and can be found in California, Florida, Illinois, Kentucky, New England, New York Metro, and Texas. HD Smith also operates subsidiaries Smith Medical Partners, and Valley Wholesale Drug.

Prometheus Laboratories Inc. provide diagnostics which enable unique health solutions. Considered as a leader of precision healthcare in gastroenterolgy, it develops and brings to the market diagnostic tests that help physicians provide the highest level of patient care. Since 2011, it has been a part of Nestle Health Science, aiming to change the way people approach and manage their health.

Johnson & Johnson engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company operates through three business segments, including Consumer; Pharmaceutical and Medical Devices; and Diagnostics. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. The Baby Care franchise includes the JOHNSON'S Baby line of products. Major brands in the Skin Care franchise include the AVEENO; CLEAN & CLEAR; JOHNSON'S Adult; NEUTROGENA; RoC; LUBRIDERM; Beijing Dabao Cosmetics Co., Ltd.; and Vendome product lines. The Oral Care franchise includes the LISTERINE and REACH oral care lines of products. Major brands in the Women's Health franchise are the CAREFREE Pantiliners and STAYFREE sanitary protection products. The nutritional and over-the-counter lines include SPLENDA, No Calorie Sweetener; the family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; ZYRTEC allergy products; MOTRIN IB ibuprofen products; and PEPCID AC Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co. These products are marketed principally to the general public and sold both to wholesalers and directly to independent and chain retail outlets throughout the world. Pharmaceutical The Pharmaceutical segment includes products in the following therapeutic areas: anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use by the general public. Key products in the Pharmaceutical segment include: REMICADE (infliximab), a biologic approved for the treatment of Crohn's disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and use in the treatment of rheumatoid arthritis; TOPAMAX (topiramate), approved for adjunctive and monotherapy use in epilepsy, as well as for the prophylactic treatment of migraines; PROCRIT (Epoetin alfa, sold outside the U.S. as EPREX), a biotechnology-derived product that stimulates red blood cell production; RISPERDAL oral (risperidone), a medication that treats the symptoms of schizophrenia, bipolar mania and irritability associated with autistic behavior in indicated patients, RISPERDAL CONSTA (risperidone), a long-acting injectable, and INVEGA (paliperdone) Extended-Release tablets, for the treatment of schizophrenia; LEVAQUIN (levofloxacin) and FLOXIN (ofloxacin), both in the anti-infective field; CONCERTA (methylphenidate HCl), a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor co-marketed with Eisai Inc.; and DURAGESIC/Fentanyl Transdermal (fentanyl transdermal system, sold outside the U.S. as DUROGESIC), a treatment for chronic pain that offers a novel delivery system. Medical Devices and Diagnostics The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Cordis' circulatory disease management products; DePuy's orthopaedic joint reconstruction, spinal care and sports medicine products; Ethicon's surgical care and women's health products; Ethicon Endo-Surgery's minimally invasive surgical products; LifeScan's blood glucose monitoring and insulin delivery products; Ortho-Clinical Diagnostics' professional diagnostic products and Vistakon's disposable contact lenses.

Wyeth, LLC was an American pharmaceutical company. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. It was later known as American Home Products before being renamed to Wyeth in 2002.

Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

IBA Molecular is a leading developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging with operations throughout Europe and Asia. IBAM has a unique product portfolio and pipeline of diagnostic and therapeutic tracers aimed at advancing the development of the global movement towards personalized medicine and making molecular imaging/therapy a major discipline in healthcare. The Company also provides educational, technical and marketing support to medical specialists worldwide to help better respond to patient needs. IBA Molecular is jointly owned by SK Capital Partners and Ion Beam Applications S.A.

Meda Pharmaceuticals Inc. provides pharmaceutical products Europe, the United States, and internationally. The company s portfolio primarily focuses on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women's health products. Its products include inhalation and topical aerosols, tablets, creams, nasal sprays, flavored soluble powders, capsules, rectal and hemorrhoidal foams, gels, oral concentrates, injections, oral and extended-release tablets, chewable melt tablets, softgels, rectal suspensions, and ophthalmic solutions. Meda Pharmaceuticals Inc. was formerly known as MedPointe, Inc. and changed its name to Meda Pharmaceuticals Inc. in August 2007. The company was founded in 2001 and is based in Somerset, New Jersey. As of August 22, 2007, Meda Pharmaceuticals Inc. operates as a subsidiary of Meda AB.

Navitus Health Solutions LLC is a full service, URAC-accredited pharmacy benefit management

Luitpold Pharmaceuticals earns its gold from the businesses of drugs and medical devices. Luitpold markets and manufactures injectable products used to treat an array of ailments including kidney disease. Luitpold also manufactures materials used in dental bone grafting and bone regeneration; pain medications; and treatments for equine and canine joint diseases. The company, which targets its products primarily to hospitals and clinics in US and Canadian markets, operates through divisions including American Regent, Animal Health, and Osteohealth. It is also a contract manufacturer. Originally a German company named after a Bavarian prince, Luitpold is a subsidiary of one of Japan's largest pharmaceutical companies, Daiichi Sankyo.

DSM Pharmaceuticals, Inc. provides custom manufacturing services to the pharmaceutical and biopharmaceutical industries. It offers a range of manufacturing services in the areas of steriles, and orals and topicals, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, aseptic filling, terminal sterilization, cold storage, ampoules, vials, and lyophilization. The company was formerly known as Catalytica Pharmaceuticals, Inc. and changed its name to DSM Pharmaceuticals, Inc. in December 2001. The company was founded in 1993 and is based in Greenville, North Carolina.

Anda, Inc. operates as a wholesale distributor of pharmaceutical products in the United States. It distributes generic, branded, and specialty pharmaceuticals, as well as CII products, vaccines, injectables, medical/surgical supplies, and OTCs/vitamins to independent pharmacies, hospitals, nursing homes, mail order pharmacies, pharmacy chains, and physicians' offices. The company markets products through phone, fax, and online orders. Anda, Inc. was formerly known as Anda Generics, Inc. and changed its name to Anda, Inc. in October 1999. The company was founded in 1992 and is based in Weston, Florida. Anda, Inc. operates as a subsidiary of Watson Pharmaceuticals, Inc.

G & W Laboratories, Inc. develops, manufactures, and markets pharmaceutical products. It offers generics, over-the-counter and prescription products, creams, ointments, suppositories, topical solutions, topical creams, and suppositories USP. The company also provides contract manufacturing services, including formulation development, analytical method research and development, analytical method validation, pilot batches, scale-up batches, process validation, cleaning validation, and commercial batch production. It exports its products to various countries around the world. The company offers its products through retailers, distributors, and wholesalers. G & W Laboratories, Inc. was founded in 1918 and is based in South Plainfield, New Jersey.

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical treatments for metabolic and cardiovascular disease, central nervous system disease, respiratory and immunology, oncology, and general medicine areas. It offers products for the treatment of type II diabetes, hypertension, insomnia, Alzheimer s-type dementia, hyperuricemia and gout, peptic ulcer, acid reflux, multiple myeloma, prostate and breast cancer, endometriosis, cancer, malignant lymphoma, and major depressive disorder diseases. The company was founded in 1998 and is based in Deerfield, Illinois. It has business and sales operations in Europe, the Russian Federation, CIS, Japan, North America, Latin America, Asia, and internationally. Takeda Pharmaceuticals U.S.A., Inc. operates as a subsidiary of Takeda Pharmaceutical Company Limited.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). This company is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes.

ExecuPharm is a Global Functional Service Contract Research Organization, certified by the Women's Business Enterprise National Council (WBENC), who provides clinical research support services for the pharmaceutical industry. ExecuPharm's distinctive business model incorporates flexible models of service and technologies to support every aspect of a clinical trial. ExecuPharm, with a core management team with extensive clinical operations experience, understands clinical trial challenges and how to solve clinical outsourcing, staffing, placement, technology and process needs. 21+ years of Experience Meeting Client Needs 15,000+ Global Clinical Operational Specialists In Network 80% of Recruiting Staff with >15 Years of Experience Talent Acquisition, Deployment Rates, and Employee Retention above 90% Management Staff with Tangible Industry Experience Greater Than 95% Repeat Business Average Turnaround Time of 14 Days To Deploy Project Team Resources Global Capabilities ExecuPharm's clinical operations specialists are well versed in country and regional customs, business practices as well as regulatory and ethical restrictions and considerations. Having a resource that knows the culture, speak the language and is close in proximity to trial sites will aid in resolving any issues pertaining to the trial in a fast and efficient manner. ExecuPharm global locations are as follows: King of Prussia, Pennsylvania, United States - North America Nova Scotia, Canada - North America Mexico City, Mexico - North America Buenos Aries, Argentina - South America Chichester, United Kingdom - Europe Bangalore, India - Asia Shanghai, China - Asia Tokyo, Japan - Asia

Alvogen is an international, privately-owned specialty pharmaceutical company focused on the development, manufacturing and marketing of generic pharmaceuticals, biosimilar products and OTC (over-the-counter medicines). Alvogen's lines of business include generic sales and marketing (Gx), product development, contract manufacturing (CMO) and contract research (CRO).

Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The Company uses its proprietary osmotic technology platform and with strategic partners develops and commercializes high quality pharmaceutical products.

Learn how we develop, manufacture and commercialize precision diagnostics and radiopharmaceuticals to Find, Fight and Follow disease.

Sun Pharmaceutical Industries Inc. develops, licenses, manufactures, markets, and distributes generic, prescription, and over-the-counter pharmaceuticals to wholesalers, distributors, warehousing and non-warehousing chain drugstores, and managed care providers. Its products are intended to treat disorders, including hypertension, arthritis, epilepsy, diabetes, depression, and pain management. The company was formerly known as Caraco Pharmaceutical Laboratories Ltd. and changed its name to Sun Pharmaceutical Industries Inc. in April 2014. The company was founded in 1984 and is based in Cranbury, New Jersey. Sun Pharmaceutical Industries Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

Amneal is much more than just a company. It is a remarkable collection of dynamic and innovative people dedicated to the constant pursuit of excellence.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world. Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Nexgen Pharma is a specialty pharmaceutical company that provides development and manufacturing services for Rx, OTC drugs as well as custom dietary supplement formulations. Nexgen Pharma has over 80 years of manufacturing experience with a rigorous commitment to quality and customer service.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. Our global network, including the emerging markets of Central Eastern Europe, Latin America, and India enables us to recruit patients on-time for even the most challenging studies. By accelerating enrolment, we reduce costs for our sponsors and take trials to the next Phase faster. From pre-clinical to Phase IV, POI is focused on delivering the highest quality data, achieving targeted enrolment and meeting projected timelines.

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.

TrialCard is the largest provider of patient access resources in the industry; yet, they still pride ourselves on creating innovative, individualized solutions that meet the needs of your brand. They take the opportunity to partner with you to maximize brand exposure, solve for your brand challenges, and increase patient engagement and adherence. TrialCard was built - and continues to grow - through the hard work of dedicated, smart people who believe that the best solutions come from listening to the needs of their clients and working tirelessly to provide inventive solutions.

Teligent develop, manufacture and market pharmaceutical products for use by doctors and patients in the United States and Canada. They are a dynamic group of about 130 employees based in New Jersey, Toronto, Montreal and Tallinn, Estonia. Their Product Development and Manufacturing complex is in Buena, New Jersey, approximately 45 minutes from Philadelphia. In 2015 They acquired Alveda Pharmaceuticals Inc., a Toronto-based pharmaceutical company focused on the Canadian injectable pharmaceutical market. In 2016 They hired Their first European colleagues in Tallinn who support Their supply chain and quality operations.

Sumitomo Corporation is one of the largest worldwide Sogo shosha general trading companies, and is a diversified corporation. The company was incorporated in 1919 and is a member company of the Sumitomo Group. It is listed on four Japanese stock exchanges and is a constituent of the TOPIX and Nikkei 225 stock indices.

Eli Lilly and Company is known for their high-quality medicines which are being distributed to 125 countries. Founded in 1876 by Col. Eli Lilly, this global pharmaceutical company remains committed to his vision through every aspect of their business and the people they serve, starting with those who take their medicines, and extending to health care professionals, employees and the communities in which they live. They currently have up to $1 billion in revenue and around 10,000 employees.